Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats.
about
In vitro and in vivo protein release and anti-ischemia/reperfusion injury properties of bone morphogenetic protein-2-loaded glycyrrhetinic acid-poly(ethylene glycol)-b-poly(l-lysine) nanoparticles.Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles.Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus.
P2860
Simvastatin nanoparticles attenuated intestinal ischemia/reperfusion injury by downregulating BMP4/COX-2 pathway in rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@en
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@nl
type
label
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@en
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@nl
prefLabel
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@en
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@nl
P2093
P2860
P356
P1476
Simvastatin nanoparticles atte ...... ng BMP4/COX-2 pathway in rats.
@en
P2093
Daojun Liu
Rongkui Chai
Shipiao Chen
Xinmei Zhou
P2860
P304
P356
10.2147/IJN.S126063
P407
P577
2017-03-29T00:00:00Z